Chlorhydrate de Mébévérine Mylan Overdose

sponsored
How times a day do you take this medicine?

Overdose of Chlorhydrate de Mébévérine Mylan in details

infoWhen a dose is taken in higher dose than the recommended doses, it is called Overdose. Overdose always needs a clinical supervision. Any medicine or drug when consumed in Overdose produces untoward side effects on one or various organs in the body. A medicine is excreted in the kidney or metabolized in the liver most of the times. This process goes without any hurdles when taken in normal dose, but when taken in an overdose, the body is not able to metabolize it or send it out properly which causes the effects of anoverdose.
sponsored

In cases where Duspatalin was taken in overdose, symptoms were either absent or mild and usually rapidly reversible.

Symptoms: Theoretically, central nervous system excitability may occur in cases of overdose. In cases where Chlorhydrate de Mébévérine Mylan was taken in overdose, symptoms were either absent or mild and usually rapidly reversible. Observed symptoms of overdose were of neurological and cardiovascular nature.

Treatment: No specific antidote is known and symptomatic treatment is recommended. Gastric lavage should only be considered in case of multiple intoxication within about 1 hr. Absorption reducing measures are not necessary.

Chlorhydrate de Mébévérine Mylan warnings

infoWarnings are a mix of Precautions. Contraindications and interactions and serious harmful effects associated with the medicine intake. A diabetic or Hypertensive patient need to be warned about few drug interactions. A known hypersensitivity patient needs to be careful about the reactions or anaphylactic shock. A pregnant woman or a breastfeeding woman should be warned of certain medications. A Hepatitis [liver disease] patient or a cardiac patient should avoid few drugs.

Chlorhydrate de Mébévérine Mylan has proved to be well- tolerated in therapeutic doses.

Though experiments in rats and rabbits have shown Chlorhydrate de Mébévérine Mylan hydrochloride not to be teratogenic, Chlorhydrate de Mébévérine Mylan is better avoided during pregnancy.

Chlorhydrate de Mébévérine Mylan precautions

infoCertain people who are very sick or very old or who are sensitive show an exacerbation of side effect of the drug which can turn dangerous at times. So, it is very important to remember the precautions while taking the medicine. Pregnancy and Breastfeeding are also special categories wherein extra care or precaution is needed when taking a drug. Few patients may have a hypersensitivity reaction to few medications, and that can be life-threatening rarely. Penicillin hypersensitivity is one example. Diarrhea, rashes are few other symptoms which need a watch. A patient with other co-existing diseases like liver disease, heart disease, kidney disease should take special precautions.

Effects on the Ability to Drive or Operate Machinery: No studies on the effects on the ability to drive and use machines have been performed. The pharmacodynamic and pharmacokinetic profile as well as post-marketing experiences do not indicate any harmful effect of Chlorhydrate de Mébévérine Mylan on the ability to drive or to use machines.

Impairment of Fertility: There is no clinical data on male or female fertility; however, animal studies do not indicate harmful effects of Chlorhydrate de Mébévérine Mylan.

Use in pregnancy: There is no or limited amount of data from the use of Chlorhydrate de Mébévérine Mylan in pregnant women. Animal studies are insufficient with respect to reproductive toxicity. Chlorhydrate de Mébévérine Mylan is not recommended during pregnancy.

Use in lactation: It is unknown whether Chlorhydrate de Mébévérine Mylan or its metabolites are excreted in human milk. The excretion of Chlorhydrate de Mébévérine Mylan in milk has not been studied in animals. Chlorhydrate de Mébévérine Mylan should not be used while breastfeeding.

Use in children: Chlorhydrate de Mébévérine Mylan capsules are not recommended for use in children and adolescents <18 years, due to insufficient data on safety and efficacy.


sponsored

References

  1. DrugBank. "Mebeverine". http://www.drugbank.ca/drugs/DB12554 (accessed September 17, 2018).
  2. MeSH. "Parasympatholytics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2020 ndrugs.com All Rights Reserved